# Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)

> **NCT00907283** · PHASE2 · UNKNOWN · sponsor: **Ente Ospedaliero Ospedali Galliera** · enrollment: 20 (estimated)

## Conditions studied

- Neurodegenerative Disease
- Iron Overload

## Interventions

- **DRUG:** Deferiprone

## Key facts

- **NCT ID:** NCT00907283
- **Lead sponsor:** Ente Ospedaliero Ospedali Galliera
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907283, "Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00907283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*